Compare Stocks: BMY, ZIM, and MCK

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BMY Bristol Myers Squibb	$67.06 +2.4%	$60.55	$42.52 ▼ $68.64	$136.88B	0.22	12.63 million shs	6.84 million shs
MCK McKesson	$862.27 +2.8%	$820.97	$673.38 ▼ $999.00	$100.14B	0.3	1.01 million shs	1.58 million shs
ZIM ZIM Integrated Shipping Services	$28.17 +3.7%	$25.43	$12.33 ▼ $29.97	$3.40B	1.21	2.04 million shs	2.39 million shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BMY Bristol Myers Squibb	0.00%	+5.01%	+8.93%	+12.70%	+38.99%
MCK McKesson	0.00%	-0.74%	+4.55%	+12.67%	+22.86%
ZIM ZIM Integrated Shipping Services	0.00%	+0.06%	+10.13%	+11.73%	+83.18%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BMY Bristol Myers Squibb	$67.06 +2.4%	$60.55	$42.52 ▼ $68.64	$136.88B	0.22	12.63 million shs	6.84 million shs
MCK McKesson	$862.27 +2.8%	$820.97	$673.38 ▼ $999.00	$100.14B	0.3	1.01 million shs	1.58 million shs
ZIM ZIM Integrated Shipping Services	$28.17 +3.7%	$25.43	$12.33 ▼ $29.97	$3.40B	1.21	2.04 million shs	2.39 million shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BMY Bristol Myers Squibb	0.00%	+5.01%	+8.93%	+12.70%	+38.99%
MCK McKesson	0.00%	-0.74%	+4.55%	+12.67%	+22.86%
ZIM ZIM Integrated Shipping Services	0.00%	+0.06%	+10.13%	+11.73%	+83.18%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BMY Bristol Myers Squibb	2.56	Moderate Buy	$66.06	-1.50% Downside
MCK McKesson	2.78	Moderate Buy	$973.44	12.89% Upside
ZIM ZIM Integrated Shipping Services	2.25	Hold	$19.33	-31.37% Downside

Current Analyst Ratings Breakdown

Latest BMY, ZIM, and MCK Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/19/2026	MCK McKesson	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$925.00 ➝ $1,000.00
8/19/2026	MCK McKesson	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Sector Perform	$845.00
8/19/2026	MCK McKesson	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Sector Perform	$845.00
8/18/2026	BMY Bristol Myers Squibb	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C+) ➝ Buy (B-)
8/11/2026	MCK McKesson	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Equal Weight	$812.00 ➝ $933.00
8/7/2026	MCK McKesson	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight
8/6/2026	MCK McKesson	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$1,015.00
8/6/2026	MCK McKesson	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform
8/6/2026	MCK McKesson	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$989.00 ➝ $1,006.00
8/6/2026	MCK McKesson	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$1,050.00 ➝ $1,080.00
8/5/2026	BMY Bristol Myers Squibb	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Market Perform ➝ Strong-Buy

(Data available from 8/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BMY Bristol Myers Squibb	$48.19B	2.84	$8.14 per share	8.24	$10.93 per share	6.14
MCK McKesson	$403.43B	0.25	$45.74 per share	18.85	($33.14) per share	-26.02
ZIM ZIM Integrated Shipping Services	$6.90B	0.49	$13.74 per share	2.05	$32.23 per share	0.87

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BMY Bristol Myers Squibb	$7.05B	$4.54	14.77	10.41	0.17	18.87%	66.90%	14.74%	10/29/2026 (Estimated)
MCK McKesson	$4.76B	$37.37	23.07	17.31	1.69	1.12%	-253.21%	5.90%	11/4/2026 (Estimated)
ZIM ZIM Integrated Shipping Services	$479.20M	$1.15	24.50	N/A	N/A	2.15%	1.11%	0.41%	N/A

Latest BMY, ZIM, and MCK Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/19/2026	Q2 2026	ZIM ZIM Integrated Shipping Services	$0.7980	$0.53	-$0.2680	$0.53	$1.79 billion	$1.78 billion
8/5/2026	Q1 2027	MCK McKesson	$9.56	$9.93	+$0.37	$5.15	$103.88 billion	$105.38 billion
7/30/2026	Q2 2026	BMY Bristol Myers Squibb	$1.60	$2.04	+$0.44	$1.62	$11.74 billion	$12.97 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BMY Bristol Myers Squibb	$2.52	3.76%	+1.61%	55.51%	17 Years
MCK McKesson	$3.28	0.38%	+13.68%	8.78%	17 Years
ZIM ZIM Integrated Shipping Services	$0.06	0.21%	N/A	5.22%	1 Years

Latest BMY, ZIM, and MCK Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/21/2026	MCK McKesson	quarterly	$0.94	0.46%	9/1/2026	9/1/2026	10/1/2026
6/17/2026	BMY Bristol Myers Squibb	quarterly	$0.63	4.34%	7/2/2026	7/2/2026	8/3/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BMY Bristol Myers Squibb	1.89	1.53	1.38
MCK McKesson	N/A	0.89	0.52
ZIM ZIM Integrated Shipping Services	1.09	1.24	1.09

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BMY Bristol Myers Squibb	76.41%
MCK McKesson	85.07%
ZIM ZIM Integrated Shipping Services	21.42%

Insider Ownership

Company	Insider Ownership
BMY Bristol Myers Squibb	0.05%
MCK McKesson	0.06%
ZIM ZIM Integrated Shipping Services	1.30%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BMY Bristol Myers Squibb	32,500	2.04 billion	2.04 billion	Optionable
MCK McKesson	43,000	116.59 million	116.52 million	Optionable
ZIM ZIM Integrated Shipping Services	4,714	120.52 million	118.95 million	Not Optionable

BMY, ZIM, and MCK Headlines

Recent News About These Companies

Zim profit rises on Q2 revenue of $1.78 billion

August 20 at 1:21 PM | finance.yahoo.com

ZIM Integrated Shipping Services (NYSE:ZIM) Issues Quarterly Earnings Results

August 20 at 8:25 AM | marketbeat.com

ZIM reports solid results as sale remains on hold

August 20 at 8:21 AM | en.globes.co.ilE

ZIM Integrated: Good Quarter, Same Problem

August 20 at 5:00 AM | seekingalpha.com

ZIM Q2 Profit Jumps as Transpacific Strength, Higher Rates Lift Results

August 19, 2026 | marinelink.comM

ZIM: With Record Rates, A Hapag Rejection Could Unlock Greater Value (Downgrade)

August 19, 2026 | seekingalpha.com

ZIM's shares fall as weaker cash flow, merger uncertainty weigh on shares

August 19, 2026 | seekingalpha.com

ZIM Q2 Earnings Beat Estimates as Freight Rates and Volume Rise

August 19, 2026 | zacks.com

ZIM Integrated Shipping Services (NYSE:ZIM) Shares Gap Down - What's Next?

August 19, 2026 | marketbeat.com

ZIM Reports Strong Results for the Second Quarter of 2026, Benefiting from its Leading Transpacific Position, Agile Commercial Approach and Efficient Cost Structure

August 19, 2026 | finance.yahoo.com

ZIM Integrated Shipping Services (ZIM) Q2 Earnings and Revenues Surpass Estimates

August 19, 2026 | finance.yahoo.com

ZIM Shares Fall Despite Strong Second-Quarter Earnings Beat

August 19, 2026 | investorshub.advfn.com

ZIM Integrated Shipping Services (ZIM) Q2 Earnings and Revenues Surpass Estimates

August 19, 2026 | zacks.com

ZIM Reports Strong Results for the Second Quarter of 2026, Benefiting from its Leading Transpacific Position, Agile Commercial Approach and Efficient Cost Structure

August 19, 2026 | prnewswire.com

Global Retirement Partners LLC Acquires Shares of 39,357 ZIM Integrated Shipping Services Ltd. $ZIM

August 19, 2026 | marketbeat.com

Corporacion America Airports S.A. (CAAP) Q2 Earnings Miss Estimates

August 18, 2026 | finance.yahoo.com

3 Massive Yield Dividend Payers To Watch Out For

August 18, 2026 | 247wallst.com

ZIM Integrated Shipping Services (ZIM) Projected to Announce Earnings on Wednesday

August 18, 2026 | americanbankingnews.com

Mitsubishi UFJ Trust & Banking Corp Sells 206,629 Shares of ZIM Integrated Shipping Services Ltd. $ZIM

August 16, 2026 | marketbeat.com

ZIM Integrated Shipping Services Ltd. $ZIM is Yelin Lapidot Holdings Management Ltd.'s Largest Position

August 15, 2026 | marketbeat.com

Investors Buy High Volume of Call Options on ZIM Integrated Shipping Services (NYSE:ZIM)

August 14, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

BMY, ZIM, and MCK Company Descriptions

Bristol Myers Squibb NYSE:BMY

$67.06 +1.59 (+2.43%)

As of 08/21/2026 03:58 PM Eastern

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

McKesson NYSE:MCK

$862.27 +23.52 (+2.80%)

As of 08/21/2026 03:58 PM Eastern

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

ZIM Integrated Shipping Services NYSE:ZIM

$28.17 +1.01 (+3.72%)

As of 08/21/2026 03:58 PM Eastern

ZIM Integrated Shipping Services Ltd., together with its subsidiaries, provides container shipping and related services in Israel and internationally. It provides door-to-door and port-to-port transportation services for various types of customers, including end-users, consolidators, and freight forwarders. The company also offers ZIMonitor, a premium reefer cargo tracking service. As of March 1, 2024, it operated a fleet of 150 vessels, which included 134 container vessels and 16 vehicle transport vessels; and as of December 31, 2023, it operated a network of 67 weekly lines. The company was incorporated in 1945 and is headquartered in Haifa, Israel.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BMY, ZIM, and MCK Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BMY, ZIM, and MCK Earnings

Compare Dividends

Latest BMY, ZIM, and MCK Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BMY, ZIM, and MCK Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

BMY, ZIM, and MCK Company Descriptions

Bristol Myers Squibb NYSE:BMY

McKesson NYSE:MCK

ZIM Integrated Shipping Services NYSE:ZIM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BMY, ZIM, and MCK Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BMY, ZIM, and MCK Earnings

Compare Dividends

Latest BMY, ZIM, and MCK Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BMY, ZIM, and MCK Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

BMY, ZIM, and MCK Company Descriptions

Bristol Myers Squibb NYSE:BMY

McKesson NYSE:MCK

ZIM Integrated Shipping Services NYSE:ZIM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools